Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 15 of 39

  1. Group 1 Standard of Care

    Pacira Ireland Limited

    Retraction of Colostomy

    approved small molecule completed

    1 trial
  2. Group A (the standard 2HRZE/4HR regimen)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Tuberculosis TB in Sputum: (+) Microscopy

    approved small molecule completed

    1 trial
  3. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial
  4. Guanfacine hydrochloride (TAK-503)

    Takeda

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial
  5. Guilingji Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oligospermia

    approved small molecule active

    1 trial
  6. Guli capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    approved small molecule active

    1 trial
  7. Guselkumab

    Janssen Cilag International NV

    Arthritis, Psoriatic

    approved small molecule active

    3 trials
  8. Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial
  9. H1N1 influenza A Vaccine (PANFLU.1)

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  10. H1N1 influenza A Vaccine (Split virion), Inactivated

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  11. HALOPERIDOL, CLOZAPINE, TIAPRIDE, SERTINDOLE, PALIPERIDONE, OLANZAPINE, SULPIRIDE, ARIPIPRAZOLE, LURASIDONE, RISPERIDONE, AMISULPRIDE, CHLORPROMAZINE, PIMOZIDE, QUETIAPINE

    Disc Medicine

    HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.

    approved small molecule active

    1 trial
  12. HTX-011

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    6 trials
  13. HTX-011

    Heron Therapeutics

    Postoperative Pain

    approved small molecule completed

    8 trials
  14. HUMAN SERUM ALBUMIN, SODIUM CHLORIDE

    The George Institute

    descompensated hepatic cirrosis

    approved small molecule active

    1 trial
  15. HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.

    The George Institute

    Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).

    approved small molecule active

    1 trial
  16. HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE

    The George Institute

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  17. HYQVIA

    Takeda

    Primary Immunodeficiency Diseases (PID)

    approved mab completed

    2 trials
  18. Haloperidol

    United Therapeutics Europe Ltd

    Migraine Headaches

    approved small molecule terminated

    1 trial
  19. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial
  20. Healive (hepatitis A vacine(human diploid cell), inactivated)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab active

    1 trial
  21. Healive+Healive

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial
  22. Healive® Lot 1

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial
  23. Heliox inspirate

    United Therapeutics Europe Ltd

    Work of Breathing

    approved small molecule active

    1 trial
  24. Hemlibra 150 mg/mL solution for injection

    Hoffmann-La Roche

    Severe or Moderate Hemophilia A

    approved small molecule active

    1 trial
  25. Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection

    Disc Medicine

    Congenital Haemophilia A

    approved small molecule active

    1 trial
  26. Hemodialysis with Polymethylmethacrylate Artificial Kidney

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uremia

    approved other completed

    1 trial
  27. Henagliflozin Proline Tablets treatment

    The First People's Hospital of Lianyungang

    Diabetes Type 2

    approved small molecule active

    1 trial
  28. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial
  29. Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient

    Biocodex

    Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))

    approved small molecule active

    1 trial
  30. Hidrathea 9 mg/ml colirio en solución, Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución

    Wuhan Createrna Science and Technology Co., Ltd

    Dry Eye Disease

    approved small molecule active

    1 trial
  31. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial
  32. High-dosage of COVID-19 vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  33. High-dose anrikefon

    The First People's Hospital of Lianyungang

    Laparoscopic Surgery

    approved small molecule active

    2 trials
  34. Honghe Fujie lotion

    The First People's Hospital of Lianyungang

    Bacterial Vaginitis

    approved small molecule active

    1 trial
  35. Humira 40 mg solution for injection in pre-filled pen, ORENCIA 125 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe, Reumaflex 50 mg/ml soluzione iniettabile, siringa preriempita, ORENCIA 250 mg powder for concentrate for solution for infusion, Cosentyx 150 mg solution for injection in pre-filled syringe, Enbrel 25 mg solution for injection in pre-filled syringe, Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Jylamvo 2 mg/ml oral so

    Istituto Gentili S.r.l.

    Juvenile idiopathic arthritis

    approved small molecule active

    1 trial
  36. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial
  37. Hydroxychloroquine Sulfate

    The First People's Hospital of Lianyungang

    Primary IgA Nephropathy

    approved small molecule completed

    1 trial
  38. Hydroxychloroquine Sulfate 200 Mg Tablet

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial
  39. Hylenex

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    2 trials
  40. Hyperbaric bupivacaine+Sufentanil

    Lxo Ireland Designated Activity Company

    Anesthesia; Functional

    approved small molecule completed

    1 trial
  41. Hypo-osmolar ORS

    United Therapeutics Europe Ltd

    Diarrhoea

    approved small molecule completed

    1 trial
  42. ICD Ablation plus VT-ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    1 trial
  43. ICS+LABA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis

    approved small molecule completed

    1 trial
  44. ICS/LABA

    The First People's Hospital of Lianyungang

    Asthma

    approved small molecule active

    1 trial
  45. IIV4 and PPV23

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza, Human

    approved mab completed

    1 trial
  46. ILUVIEN

    ANI PHARMACEUTICALS INC

    Chronic Diabetic Macular Edema

    approved small molecule completed

    1 trial
  47. ILUVIEN 0.19 MG

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema (DME)

    approved small molecule completed

    1 trial
  48. IMATINIB , PONATINIB , BOSUTINIB, NILOTINIB, DASATINIB

    Disc Medicine

    Chronic myeloid leukaemia

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs